Vancouver, April 26, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore”) announced today the resignation of Ms. Leanne Ratzlaff as Corporate Secretary effective immediately. Due to the growth in Avricore's business and its near-term corporate objectives, it requires a full-time individual to handle its corporate secretary requirements. A search for a highly qualified, full-time individual to replace Ms. Ratzlaff is currently underway, which Avricore expects to announce in due course. Avricore thanks Leanne for her work and wishes her well.
About Avricore Health Inc.
Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. Avricore's goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.
Cautionary Note Regarding Forward-Looking Statements: Information in this press release that involves Avricore's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. Avricore generally uses words such as “outlook,” “will,” “could,” “would,” “might,” “remains,” “to be,” “plans,” “believes,” “may,” “expects,” “intends,” “anticipates,” “estimate,” “future,” “plan,” “positioned,” “potential,” “project,” “remain,” “scheduled,” “set to,” “subject to,” “upcoming,” and similar expressions to help identify forward-looking statements. In this press release, forward-looking statements include statements regarding: Avricore's search for a new Corporate Secretary and the timing thereof. Forward-looking statements reflect the then-current expectations, beliefs, assumptions, estimates and forecasts of Avricore’s management. The forward-looking statements in this press release are based upon information available to Avricore as of the date of this press release. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of Avricore and are subject to a number of risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations, including without limitation: failure to negotiate and enter into a definitive agreement with Molecular You; failure to meet regulatory requirements; changes in the market; potential downturns in economic conditions; and other risk factors described in Avricore's public filings available on SEDAR at www.sedar.com. Accordingly, readers should exercise caution in relying upon forward-looking statements and Avricore undertakes no obligation to publicly revise them to reflect subsequent events or circumstances, except as required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Bob Rai, Director and CEO
604-247-2639
info@avricorehealth.com
www.avricorehealth.com
Avricore Health Inc. | 2639 Viking Way, Suite 210, Richmond, B.C. V6V 3B7, Canada www.AvricoreHealth.com